Gabapentin Capsule
Product Images NDC 80425-0031

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 80425-0031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig. 1 (Fig 1)

A line graph showing mean pain scores over 8 weeks comparing Placebo and Gabapentin 3600 mg/day. The X-axis represents weeks from baseline to week 8, and the Y-axis represents the mean pain score ranging from 0 to 10. The graph indicates a 4-week dose titration period followed by a 4-week fixed dose period. Gabapentin shows a decreasing pain score trend compared to a relatively stable pain score for placebo.*

FDA Label Image

Fig. 2 (Fig 2)

A line graph showing mean pain scores over 7 weeks for three groups: placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis represents weeks, including a 3-week dose titration period and a 4-week fixed dose period. Pain scores decrease more in Gabapentin groups compared to placebo.*

FDA Label Image

Fig. 3 (Fig 3)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' compares response rates in Study 1 and Study 2. The chart shows placebo (PBO) and gabapentin (GBP) doses with response percentages, highlighting statistically significant differences.*

FDA Label Image

Fig. 4 (Fig 4)

A scatter plot comparing difference percentages versus daily dose in milligrams (mg) for Gabapentin across three studies labeled a, b, and c. The x-axis shows daily dose values (600, 900, 1200, 1800 mg), and the y-axis shows difference percentages from 2% to 22%. Study a is depicted with black squares, study b with gray squares, and study c with white squares, each representing data points at different doses.*

FDA Label Image

Formula (Formula)

The image shows a formula for calculating creatinine clearance (CLCr). The formula calculates CLCr based on age in years, weight in kilograms, serum creatinine in mg/dL, and includes a multiplication factor of 0.85 for female patients. This is a text panel presenting a pharmacokinetic or renal function calculation relevant to drug dosing.*

FDA Label Image

Gabapentin #30 (Gabapentin 300mg Cap Qty 30 Ndc 80425 0031)

Label for Gabapentin 300 mg capsule by Advanced RX of Tennessee, LLC. The label includes the product name, dosage strength, NDC 80425-0031-01, manufacturing lot number, and expiration date. The label also features storage instructions and a barcode.*

FDA Label Image

Gabapentin # (Gabapentin 300mg Cap Qty 60 Ndc 80425 0031)

Label for Gabapentin 300 mg capsules, bottle of 60, manufactured by Advanced RX of Tennessee, LLC. The label includes a barcode, lot number, expiration date, and storage instructions (store at 20°-25°C). It also contains a caution about federal law prohibiting transfer of the drug to others.*

FDA Label Image

Gabapentin #90 (Gabapentin 300mg Cap Qty 90 Ndc 80425 0031)

Label for Gabapentin 300 mg capsules, batch #90, manufactured by Advanced Rx of Tennessee, LLC in Nashville, TN. The label includes a lot number, expiration date, and storage instructions to keep the product at 20°-25°C (68°-77°F). It states this is a human prescription drug and compares it to Neurontin.*

FDA Label Image

Structure (Structure)

Chemical structure of gabapentin showing a cyclohexane ring attached to a carbon linked to amino and carboxymethyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.